Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Propanc Biopharma’s lead asset PRP demonstrated the ability to reprogram chemotherapy-resistant pancreatic cancer cells in preclinical research led by Dr. Maria Belén Toledo.
Corporación América Airports reported a 3.4% year-on-year increase in passenger traffic in September 2026, with international traffic up 7.2% and domestic traffic down 1.0%.
Medicare-related test orders for inFoods® IBS surged 120% in September 2026 compared to August, with 100% of initial valid claims paid at the full CMS rate of $300.
The State Street SPDR S&P 500 ETF Trust slipped 0.28% and the Invesco QQQ Trust fell 2.62% over the five trading sessions ended Thursday, October 15, 2026.
Aduro reported Q1 2027 income from operations of $1.2M, reversing a $6.3M loss from Q1 2026, driven by non-cash gains and lower share-based compensation.
NeOnc's NEO100 demonstrated early clinical improvement in a critically ill 3-year-old boy with an aggressive brain tumor under compassionate use in Abu Dhabi.